Literature DB >> 9815032

5-HT is present in nerves of guinea pig sphincter of Oddi and depolarizes sphincter of Oddi neurons.

K Hillsley1, G M Mawe.   

Abstract

This study involved immunohistochemistry and intracellular electrophysiology to investigate serotonergic neurotransmission in the sphincter of Oddi (SO). 5-Hydroxytryptamine (HT)-positive neurons (14 cells/preparation) and nerve fibers were observed in the ganglionated plexus. Serotonergic nerve fibers, which persisted under 2- to 6-day organ culture, were densely distributed, with varicose endings encircling some SO neurons. When 5-HT was applied to SO neurons, it elicited three different responses: 1) a fast depolarization to 5-HT in 31 of 62 cells was mimicked by 2-methyl-5-HT and blocked by LY-278584 (1 microM); 2) a prolonged depolarization to 5-HT in 21 of 62 cells evoked an increase in input resistance and was attenuated by the 5-HT1P antagonist renzapride (1 microM) but not by the 5-HT4 antagonist SDZ-205557 (0.1-10 microM); and 3) an indirect depolarization blocked by TTX or atropine was observed in 32 of 62 cells. 5-HT superfusion elicited a dose-dependent monophasic depolarization (EC50 = 2 microM, n=14). In conclusion, 5-HT is present in nerves of the SO and elicits both 5-HT3 and 5-HT1P receptor-mediated depolarizations, supporting the concept that 5-HT plays a role in SO regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815032     DOI: 10.1152/ajpgi.1998.275.5.G1018

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

Review 1.  Direct neuronal interactions between the duodenum and the sphincter of Oddi.

Authors:  A L Kennedy; G T Saccone; G M Mawe
Journal:  Curr Gastroenterol Rep       Date:  2000-04

2.  Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study.

Authors:  Qi Pauls; Valerie Durkalski-Mauldin; Olga Brawman-Mintzer; Chris Lawrence; Rebekah Whichard; Peter B Cotton
Journal:  Dig Dis Sci       Date:  2016-05-10       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.